Fiat Chrysler Automobiles NV unit Ferrari went public on late Tuesday, earning a market valuation of about USD900 million ahead of trading on the New York Stock Exchange on Wednesday, Detroit News said.
The Ferrari stock was priced at the top end of the market range, according to Bloomberg data, as they were offered at USD48 to USD52 each for all 17.18 million shares. Fiat Chrysler was selling off 9 percent stake of the iconic automobile brand.
Reuters said proceeds from the IPO will be used to support the ambitious growth plan of Fiat Chrysler, which will involve the revamp of its other automobile brands: Alfa Romeo, Jeep and Maserati. Should the IPO be successful, it will help Fiat Chrysler’s finances greatly at the time when it badly needs a merger partner to support it.
At the NYSE, Fiat Chrysler’s chief executive officer Sergio Marchionne will be ringing the opening bell with other company executives. The son of founder Enzo Ferrari, and Fiat Chrysler Chairman John Elkann, Vice Chairman Piero Ferrari, is expected to join in the opening. Ferrari shares will be trading under the ticker symbol RACE.


TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 



